AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Novel cancer vaccines report presented at Therapeutic Vaccines European Congress 2002.(Brief Article)
2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) (BRA) announced that a Biomira company representative presented at the Therapeutic Vaccine European Congress 2002, London, England. The Congress focused on therapeutic vaccines and assessed the market potential and define the critical steps towards profitability for companies working in this field.
Guy Ely, MD, vice president, clinical and regulatory affairs, provided insight on Biomira's therapeutic vaccine program in a presentation titled "Theratope Vaccine-A Case Study of the Journey from Bench Top to the Final Phase of Clinical Testing."
"We are pleased to share our many years of experience in developing cancer vaccines. We believe these treatments may offer an effective way to manage cancer without the side effects of conventional treatment," said Ely. "Biomira believes that its ...
- Examine the Cancer Vaccines: Market Forecasts, New Developments and Pipeline...
- Press release article from: Business Wire November 4, 2008 700+ words
...industry is available in its catalogue. Cancer Vaccines: Market Forecasts, New Developments...www.reportlinker.com/p096701/Cancer-Vaccines-Market- Forecasts-New-Developments...general consensus of scientists that cancer vaccines will become a reality. Overall the...
- Cancer Vaccines are the Newest Weapon in the Battle Against Cancer.
- Press release article from: M2 Presswire August 14, 2007 700+ words
...August 2007-Research and Markets: Cancer Vaccines are the Newest Weapon in the Battle...COMMUNICATIONS LTD RDATE:16082007 Cancer Vaccines are the Newest Weapon in the Battle...Resource report "Building Better Cancer Vaccines: The Progress and Promise of R...
- Research and Analysis of the Cancer Vaccines Pipeline.
- Press release article from: M2 Presswire April 5, 2007 700+ words
...Markets: Research and Analysis of the Cancer Vaccines Pipeline(C)1994-2007 M2 COMMUNICATIONS...of "Pipeline Insight: Therapeutic Cancer Vaccines - A Turbulent Path from Bench to Bedside...specificity and high toxicity. Therapeutic cancer vaccines offer an attractive therapeutic ...
- The Overall Market for Cancer Treatments is Expected to Expand Due to the...
- Press release article from: Business Wire March 21, 2006 700+ words
...biologic therapies. Developers of cancer vaccines will be able to use this acceptance...approval and commercial success of cancer vaccines. These factors contribute to a cautious...autologous vaccines. - Ultimately, cancer vaccines could find their place among chemotherapy...
- In This Book A Team Of Expert Contributors Take A Focused Look At The Hot...
- Press release article from: M2 Presswire February 15, 2008 700+ words
...Focused Look At The Hot Emerging Area Of Cancer Vaccines And Tumour Immunity(C)1994-2008...has announced the addition of "Cancer Vaccines and Tumour Immunity" to their offering...focused look at the hot emerging area of cancer vaccines and tumour immunity. Cancer ...
- Cell Genesys Reacquires Full Commercial Rights to GVAX(R) Lung Cancer Vaccines.
- Press release article from: PR Newswire October 18, 2002 700+ words
...commercial rights to GVAX(R) lung cancer vaccines following the termination of its remaining...commercial rights to all of our GVAX(R) cancer vaccines, particularly as these products advance...collaboration agreement for GVAX(R) cancer vaccines in December 1998. The agreement...
- With over 120 Cancer Vaccines - Examine the Latest Drug Pipeline Updates in...
- Newspaper article from: Cancer Vaccine Week March 2, 2009 700+ words
...researchandmarkets.com/research/80cc74/cancer_vaccines_d) has announced the addition of the "Cancer Vaccines: Drug Pipeline Update 2009" report...see also Research and Markets). Cancer vaccines offer an attractive therapeutic addition...
- Cancer Vaccines Facing Difficult Clinical Trial Challenges; Greystone...
- Press release article from: Business Wire March 20, 2006 700+ words
AMHERST, N.H. -- Therapeutic cancer vaccines continue to grab our attention, as...the results of clinical trials for cancer vaccines to date have been mixed and often...away. Clinical trial endpoints for cancer vaccines include criteria on tumor shrinkage...
- With Over a 120 Cancer Vaccines - Examine the Latest Drug Pipeline Updates in...
- Press release article from: M2 Presswire February 19, 2009 700+ words
...Research and Markets: With Over a 120 Cancer Vaccines - Examine the Latest Drug Pipeline...researchandmarkets.com/research/9e457e/cancer_vaccines_d) has announced the addition of the "Cancer Vaccines: Drug Pipeline Update 2009" report...
- Massachusetts Company Works to Develop Cancer Vaccines.
- News wire article from: Boston Globe (Boston, MA) November 15, 2000 700+ words
...Ronald Rosenberg Nov. 15--Mention "cancer vaccines" and some people might be disappointed...those preventative vaccines, the cancer vaccines now on the drawing board are primarily...particularly in treating skin cancer, no cancer vaccines have yet been approved for sale by...
Source: HighBeam Research, Novel cancer vaccines report presented at Therapeutic Vaccines...